Rieke Fischer

Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas

Andreas H. Scheel, Manfred Dietel, Lukas C. Heukamp et al. · Modern Pathology · 2016 · 345 citations · Full text

Advanced Lung Disease, Immunology, Bronchial Neoplasm +6

Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors

Sandra Ortiz‐Cuaran, Matthias Scheffler, Dennis Plenker et al. · Clinical Cancer Research · 2016 · 259 citations · Full text

K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways

Matthias Scheffler, Michaela A. Ihle, Rebecca Hein et al. · Journal of Thoracic Oncology · 2018 · 247 citations · Full text

Clinical and Pathological Characteristics of <i>KEAP1</i> - and <i>NFE2L2</i> -Mutated Non–Small Cell Lung Carcinoma (NSCLC)

Rieke Frank, Matthias Scheffler, Sabine Merkelbach‐Bruse et al. · Clinical Cancer Research · 2018 · 161 citations

Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial

Sebastian Michels, Bartomeu Massutí, Hans‐Ulrich Schildhaus et al. · Journal of Thoracic Oncology · 2019 · 128 citations · Full text

Oncology, Cancer Management, Pathology +6